TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 53 filers reported holding TRANSLATE BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,382,000 | +179.3% | 376,993 | +67.3% | 2.17% | +146.1% |
| Q1 2021 | $3,717,000 | -10.5% | 225,393 | 0.0% | 0.88% | -28.6% |
| Q4 2020 | $4,154,000 | +59.8% | 225,393 | +18.1% | 1.24% | +46.3% |
| Q3 2020 | $2,599,000 | +77.5% | 190,930 | +6.2% | 0.84% | +68.0% |
| Q4 2019 | $1,464,000 | -59.4% | 179,845 | -50.6% | 0.50% | -63.0% |
| Q3 2019 | $3,610,000 | +60.3% | 364,229 | +104.3% | 1.36% | +60.3% |
| Q2 2019 | $2,252,000 | +31.2% | 178,306 | -22.1% | 0.85% | -0.8% |
| Q4 2018 | $1,717,000 | +13.2% | 228,939 | +50.9% | 0.85% | +37.1% |
| Q3 2018 | $1,517,000 | +499.6% | 151,739 | +658.7% | 0.62% | +428.0% |
| Q2 2018 | $253,000 | – | 20,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
| Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
| Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
| RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
| Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
| Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
| Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
| Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |